Peter J. Blott, EVP & CFO at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), bought 4,750 shares at $16.78 ($80K) on 2009-03-11, disclosed to the SEC on 2009-03-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.